Commerce Bank Vertex Pharmaceuticals Inc Transaction History

Commerce Bank

$16.1 Billion
Q3 2024

A detailed history of Commerce Bank transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Commerce Bank holds 7,443 shares of VRTX stock, worth $3.36 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

7,443

Previous 6,668 11.62%

Holding current value

$3.36 Million

Previous $3.13 Million 10.75%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$460.0 - $505.78 $356,500 - $391,979	775 Added 11.62%	7,443 $3.46 Million
Q2 2024 Aug 12, 2024	BUY	$392.81 - $485.53 $3,142 - $3,884	8 Added 0.12%	6,668 $3.13 Million
Q1 2024 May 03, 2024	SELL	$407.69 - $446.08 $148,399 - $162,373	-364 Reduced 5.18%	6,660 $2.78 Million
Q4 2023 Feb 09, 2024	BUY	$343.0 - $410.68 $30,527 - $36,550	89 Added 1.28%	7,024 $2.86 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $39,228 - $42,045	-116 Reduced 1.65%	6,935 $2.41 Million
Q2 2023 Aug 08, 2023	BUY	$314.42 - $351.91 $90,867 - $101,701	289 Added 4.27%	7,051 $2.48 Million
Q1 2023 May 04, 2023	SELL	$283.23 - $323.1 $127,736 - $145,718	-451 Reduced 6.25%	6,762 $2.13 Million
Q4 2022 Feb 10, 2023	BUY	$285.76 - $321.48 $134,878 - $151,738	472 Added 7.0%	7,213 $2.08 Million
Q3 2022 Nov 04, 2022	BUY	$273.83 - $305.53 $19,715 - $21,998	72 Added 1.08%	6,741 $1.95 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $23,026 - $28,669	-98 Reduced 1.45%	6,669 $1.88 Million
Q1 2022 May 09, 2022	BUY	$221.42 - $260.97 $305,116 - $359,616	1,378 Added 25.57%	6,767 $1.77 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $82,132 - $103,680	464 Added 9.42%	5,389 $1.18 Million
Q3 2021 Nov 09, 2021	SELL	$181.39 - $202.99 $53,328 - $59,679	-294 Reduced 5.63%	4,925 $893,000
Q2 2021 Aug 09, 2021	SELL	$187.49 - $221.1 $59,809 - $70,530	-319 Reduced 5.76%	5,219 $1.05 Million
Q1 2021 May 05, 2021	BUY	$207.02 - $241.31 $75,148 - $87,595	363 Added 7.01%	5,538 $1.19 Million
Q4 2020 Feb 09, 2021	SELL	$207.01 - $276.09 $65,001 - $86,692	-314 Reduced 5.72%	5,175 $1.22 Million
Q3 2020 Nov 06, 2020	BUY	$255.65 - $303.1 $139,840 - $165,795	547 Added 11.07%	5,489 $1.49 Million
Q2 2020 Aug 07, 2020	SELL	$225.48 - $295.8 $185,119 - $242,851	-821 Reduced 14.25%	4,942 $1.44 Million
Q1 2020 May 08, 2020	BUY	$199.77 - $247.81 $300,853 - $373,201	1,506 Added 35.38%	5,763 $1.37 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $88,523 - $118,896	531 Added 14.25%	4,257 $932,000
Q3 2019 Nov 12, 2019	BUY	$166.23 - $187.09 $24,435 - $27,502	147 Added 4.11%	3,726 $631,000
Q2 2019 Aug 07, 2019	BUY	$164.61 - $190.37 $17,119 - $19,798	104 Added 2.99%	3,579 $657,000
Q1 2019 May 08, 2019	BUY	$163.73 - $194.7 $15,226 - $18,107	93 Added 2.75%	3,475 $639,000
Q4 2018 Feb 11, 2019	BUY	$151.91 - $192.21 $146,441 - $185,290	964 Added 39.87%	3,382 $561,000
Q3 2018 Nov 02, 2018	BUY	$167.73 - $192.74 $6,709 - $7,709	40 Added 1.68%	2,418 $466,000
Q2 2018 Aug 08, 2018	BUY	$145.72 - $169.96 $53,333 - $62,205	366 Added 18.19%	2,378 $404,000
Q1 2018 May 03, 2018	BUY	$151.6 - $177.13 $11,370 - $13,284	75 Added 3.87%	2,012 $328,000
Q4 2017 Feb 12, 2018	BUY	$137.28 - $155.55 $45,988 - $52,109	335 Added 20.91%	1,937 $290,000
Q3 2017 Nov 07, 2017	SELL	$148.13 - $162.24 $14,813 - $16,224	-100 Reduced 5.88%	1,602 $206,000
Q3 2017 Nov 07, 2017	BUY	$148.13 - $162.24 $252,117 - $276,132	1,702	1,702 $259,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.

Account